Pancreatic Cancer Research

ResearcherTechnical University of MunichActive in the last 2 years

Stefanie Höfer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-0489-6854; OpenAlex author ID A5040252713. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. Co-author DOI 10.1038/s44320-025-00085-6↗
  2. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction. Co-author DOI 10.1002/advs.202307695↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximilian Reichert · 2 shared papers, 2024–2025 · strength 0.35
  2. Bernhard Küster · 2 shared papers, 2024–2025 · strength 0.35
  3. Hendrik Schürmann · 1 shared paper, 2025 · strength 0.21
  4. Valentina Leone · 1 shared paper, 2025 · strength 0.21
  5. Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.21
  6. Christian Schneeweis · 1 shared paper, 2024 · strength 0.14
  7. Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.14
  8. Chiara Falcomatà · 1 shared paper, 2024 · strength 0.14
  9. Marian Grade · 1 shared paper, 2024 · strength 0.14
  10. Felix Orben · 1 shared paper, 2024 · strength 0.14
  11. Aristeidis Papargyriou · 1 shared paper, 2024 · strength 0.14
  12. Lukas Krauß · 1 shared paper, 2024 · strength 0.14
  13. Constanza Tapia Contreras · 1 shared paper, 2024 · strength 0.14
  14. Carolin Schneider · 1 shared paper, 2024 · strength 0.14
  15. Roland Rad · 1 shared paper, 2024 · strength 0.14
  16. Günter Schneider · 1 shared paper, 2024 · strength 0.14
  17. Elisabeth Heßmann · 1 shared paper, 2024 · strength 0.14
  18. Matthias Wirth · 1 shared paper, 2024 · strength 0.14
  19. Volker Ellenrieder · 1 shared paper, 2024 · strength 0.14
  20. Dieter Saur · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.